1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose has been researched along with quinoxalines in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, DH; Kang, DG; Kwon, TO; Lee, HS; Lee, JK; Moon, MK | 1 |
1 other study(ies) available for 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and quinoxalines
| Article | Year |
|---|---|
Vasodilatory and anti-inflammatory effects of the 1,2,3,4,6-penta-O-galloyl-beta-D-glucose (PGG) via a nitric oxide-cGMP pathway.
Topics: Animals; Anti-Inflammatory Agents; Aorta, Thoracic; Blotting, Western; Carotid Arteries; Cell Adhesion; Cell Line; Chemokine CCL2; Cyclic GMP; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Inhibitors; Gene Expression; Guanylate Cyclase; Humans; Hydrolyzable Tannins; In Vitro Techniques; Intercellular Adhesion Molecule-1; Male; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxadiazoles; Paeonia; Plant Bark; Plant Roots; Quinoxalines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Tumor Necrosis Factor-alpha; U937 Cells; Umbilical Veins; Vascular Cell Adhesion Molecule-1; Vasodilation; Vasodilator Agents | 2005 |